Immunome, Inc.IMNMNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 14 | 9↓35.5% |
| Gross Profit | -1 | 0 | 0 | 14 | 9↓35.5% |
| Operating Income | -12 | -25↓105.6% | -37↓46.4% | -110↓196.8% | -306↓179.2% |
| Net Income | -18 | -25↓38.5% | -37↓49.3% | -107↓189.5% | -293↓174.3% |
| EBITDA | -17 | -24↓43.5% | -36↓48.3% | -28↑22.8% | -151↓440.6% |
| EPS Diluted | -1.69 | -2.14↓26.6% | -3.09↓44.4% | -5.38↓74.1% | -5.00↑7.1% |